Insulet Corp. (PODD)
160.51
+9.00
(+5.94%)
USD |
NASDAQ |
Jun 09, 14:22
Insulet SG&A Expense (Quarterly) : 317.20M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Boston Scientific Corp. | 1.781B |
| DexCom, Inc. | 349.70M |
| Abbott Laboratories | 3.74B |
| Intuitive Surgical, Inc. | 613.30M |
| MiniMed Group, Inc. | 0.00 |